Nestle Healthcare Nutrition, Inc v. Xcel Med, LLC

CourtDistrict Court, N.D. Illinois
DecidedDecember 7, 2022
Docket1:19-cv-08225
StatusUnknown

This text of Nestle Healthcare Nutrition, Inc v. Xcel Med, LLC (Nestle Healthcare Nutrition, Inc v. Xcel Med, LLC) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Nestle Healthcare Nutrition, Inc v. Xcel Med, LLC, (N.D. Ill. 2022).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

NESTLÉ HEALTHCARE NUTRITION, INC., a Delaware corporation,

Plaintiff, Case No. 19 C 8225

v. Judge Harry D. Leinenweber

XCEL MED, LLC, an Illinois Limited Liability Company,

Defendant.

MEMORANDUM OPINION AND ORDER

This is the second round of Cross-Motions for Summary Judgment the parties have filed. The first Motions were limited to what the parties referred to as “a question of law:” whether the purchase agreement imposed an obligation on Xcel to purchase medical nutritional products from Nestlé. (Dec. 1, 2020, Op. at 1, Dkt. No. 58.) The Court denied the Cross-Motions because the parties offered competing reasonable interpretations, the language did not unambiguously support either party’s interpretation, and because certain extrinsic evidence would be considered. The parties have now filed new Motions with their Rule 56.1 Statements of Material Facts in support of their interpretations. I. FACTUAL BACKGROUND In March of 2019, Nestlé and Xcel entered into a contract for the sale of medical nutrition products. (Def.’s Resp. to Pl.’s

Stmt. of Fact (“DSOF”) ¶5, Dkt. No. 109; Purchase Agreement, Pl.s’ Stmt. of Facts, Ex. 1, Dkt. No. 90-1.) The contract, which was to commence on April 1, 2019, was for a term of five (5) years and Nestlé agreed to sell Xcel its products at significantly reduced prices during the first two years of the agreement. (Purchase Agreement at 1.) In turn, Xcel promised to “commit to purchase a minimum of $6,500,000 and Ninety-five percent (95%) of Products each twelve month.” (Id. at 1—2.) In addition, the contact provided a detailed monitoring system to make certain that Xcel was on track to meet its commitment. (Id. at 2.) Xcel could not terminate the contract during the first two years. (Id.) Thereafter, Xcel could terminate on ninety (90) days written notice. (Id.) Nestlé, on the

other hand, could terminate the contract at any time if Xcel did not meet its purchase commitment. (Id.) In that event, Nestlé could also discontinue the price reductions. (Id.) During pre-contract negotiations, the proposed agreement went through several iterations. (DSOF ¶ 18.) Nestlé was concerned that Xcel would use the reduced-price list to negotiate a better deal with its chief competitor, Abbott Nutrition. (Id. ¶ 17.) One of Nestlé’s proposals was that Xcel could not terminate the agreement during the first year and would be required to pay a penalty fee of 10% of the Annual Dollar Commitment for each month it failed to meet its purchase requirements. (Id. ¶ 18.) The purchase requirement for this iteration was $4.5 million. (Draft Purchase

Agreement at 1, Pl.s’ Stmt. of Facts, Ex. 21, Dkt. No. 90-9.) Xcel rejected the idea of a penalty fee. (DSOF ¶ 19.) Xcel also rejected a proposal that it receive rebates in lieu of reduced prices. (Pl.’s Resp. to Def.’s Stmt. of Facts (“PSOF”) ¶ 5, Dkt. No. 108.) After lengthy negotiations the parties settled on language that included reduced prices and the purchase commitment of $6.5 million and 95% of its nutrition requirements. (Id. ¶ 18.) Xcel contends that the $6,500,000 purchase commitment was clearly understood to be “aspirational” and not an actual commitment to make an annual purchase if that amount of product. (DSOF ¶ 22.) It pointed out that it had never purchased that amount of product in any year of its existence. (PSOF ¶¶ 28—30.) The

parties dispute what was said about Xcel’s ability to purchase such a large amount. (Id.) As indicated above, the initial drafts of the agreement put the purchase commitment at $4,500,000 which was raised to the higher amount in later drafts. (Draft Purchase Agreement at 1; DSOF ¶ 1.) During negotiations, Nestlé emailed Xcel asking if “you feel confident that you will be able to reach the $6.5 million in the current proposal.” (DSOF ¶ 21.) According to Nestlé’s negotiator, Xcel’s negotiator gave him a verbal confirmation. (Id. ¶ 22.) According to Xcel, when it contacted its customers to make the switch from Abbott to Nestlé products, it received “significant” push back from some of them. (PSOF ¶ 44). The record

does not disclose the number that opposed. On June 5, 2019, just over two (2) months into the 5-year term of its agreement, Xcel sent a text message to Nestlé, stating “[w]e have decided not [to] move forward [with the purchase Agreement]. Sorry for the bad news.” (Xcel text, Pl.s’ Stmt. of Facts, Ex. 12, Dkt. No. 89-12). The very same day that it repudiated its agreement with Nestlé, Xcel executed an agreement with Abbott that contained similar terms and pricing. (DSOF ¶ 24.) While the pricing from Abbott was not disclosed to Nestlé in discovery, Xcel’s President testified that the pricing was “very close” to the pricing in the purchase agreement with Nestlé. (Id. ¶ 27). The contract with Abbott was also for five (5) years and required Xcel to purchase “at least

90% of its needs of product” in the categories described in the contract. (Id. ¶ 29.) Two days after receiving Xcel’s rejection, Nestlé sent a letter to Xcel outlining its view of Xcel’s breach and demanded it honor its commitment and, if it refused to do so, Nestlé would immediately proceed with litigation. (Id. ¶ 32). On June 12, 2019, Nestlé reiterated its position that Xcel was in violation of the contract and set forth the facts upon which it based this conclusion. (Id. ¶ 34). Nestlé also stated its intention to seek its full legal remedies including recovery of all lost sales and profits resulting from Xcel’s breach. (Id. ¶ 36). There is no evidence in the record to suggest that Xcel justified its refusal

to honor its contract with Nestlé or that Xcel ever responded in writing to Nestlé’s letters. After the breach, pursuant to a provision in the Purchase Agreement, Nestlé raised its prices to Xcel. (PSOF ¶ 57). Finally, on October 10, 2019, Nestlé formally terminated the Purchase Agreement and informed Xcel that it would “pursue any and all remedies available to it at law or in equity. (Id. ¶ 44.) It then proceeded to file this lawsuit. II. LEGAL STANDARD Summary judgment is appropriate if there is “no genuine dispute of material fact and the movant is entitled to judgment as a matter of law.” FED. R. CIV. P. 56(a). When analyzing cross

motions for summary judgment, the ordinary standard for assessing each motion remains unchanged. Blow v. Bijora, 855 F.3d 793, 797 (7th Cir. 2017). A dispute is genuine if a reasonable jury could return a verdict for the nonmoving party. Carroll v. Lynch, 698 F.3d 561, 564 (7th Cir. 2012). The relevant substantive law governs whether a fact is material. Id. When reviewing the record on a summary judgment motion, the Court must view the facts and draw reasonable inferences in the light most favorable to the nonmoving party. Scott v. Harris, 550 U.S. 372, 378 (2007). When a party who bears the burden of proof cannot establish

the existence of an element essential to their case, summary judgment must be entered against them. Berry v. Delta Airlines Inc., 260 F.3d 803, 808 (7th Cir. 2001.) III. DISCUSSION The parties disagree on the interpretation of the contract. Nestlé argues that the facts show this is a straight-forward contract that is unambiguous, and which required Xcel to purchase $6.5 million worth of its products and at least 95% of is requirements in return for price concessions. Xcel did neither and therefore it is in violation of its contractual obligations.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Scott v. Harris
550 U.S. 372 (Supreme Court, 2007)
Elise N. Berry v. Delta Airlines, Incorporated
260 F.3d 803 (Seventh Circuit, 2001)
Mary Carroll v. Merrill Lynch
698 F.3d 561 (Seventh Circuit, 2012)
Nitrin, Inc. v. Bethlehem Steel Corp.
342 N.E.2d 79 (Appellate Court of Illinois, 1976)
Royal's Reconditioning Corp. v. Royal
689 N.E.2d 237 (Appellate Court of Illinois, 1997)
Gentieu v. Tony Stone Images/Chicago, Inc.
255 F. Supp. 2d 838 (N.D. Illinois, 2003)
Wood v. . Duff-Gordon
118 N.E. 214 (New York Court of Appeals, 1917)
Nicole Blow v. Bijora, Inc.
855 F.3d 793 (Seventh Circuit, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
Nestle Healthcare Nutrition, Inc v. Xcel Med, LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/nestle-healthcare-nutrition-inc-v-xcel-med-llc-ilnd-2022.